Structure of Silybin A
CAS No.: 22888-70-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Silibinin is an antioxidant which shows inhibition of p-glycoprotein-mediated cellular efflux and obvious stability of liver cell membrane. Silibinin can be extracted from the herb of Silybum marianum (L.) Gaertn.
Synonyms: Silibinin A; Silybin; Silymarine I
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 22888-70-6 |
| Formula : | C25H22O10 |
| M.W : | 482.44 |
| SMILES Code : | O=C1[C@H](O)[C@@H](C2=CC=C(O[C@H](CO)[C@@H](C3=CC=C(O)C(OC)=C3)O4)C4=C2)OC5=CC(O)=CC(O)=C15 |
| Synonyms : |
Silibinin A; Silybin; Silymarine I
|
| MDL No. : | MFCD00872186 |
| InChI Key : | SEBFKMXJBCUCAI-HKTJVKLFSA-N |
| Pubchem ID : | 31553 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302-H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| SKOV3 cells | 100 µM | 24 hours | SIL inhibits phosphorylation of ERK and Akt. | Cancer Sci. 2022 Sep;113(9):3032-3043. |
| HK2 cells | 50 µM | 24 hours | To evaluate the effect of Silybin A on cisplatin-induced mitochondrial dysfunction and apoptosis in HK2 cells. Results showed that Silybin A improved mitochondrial function, reduced ROS production, and decreased apoptosis. | Front Pharmacol. 2017 Apr 5;8:178. |
| Primary monocytes | 20 µM | 24 hours | To investigate the effects of Silybin A on lipid metabolism in primary monocytes, results showed Silybin A had no significant effect on triglyceride levels. | Theranostics. 2025 Jan 6;15(5):2006-2034. |
| HepaRG cells | 20 µM | 24 hours | To investigate the effects of Silybin A on lipid metabolism in HepaRG cells, results showed Silybin A reduced lipid droplet content. | Theranostics. 2025 Jan 6;15(5):2006-2034. |
| HepG2 cells | 20 µM | 24 hours | To investigate the effects of Silybin A on lipid metabolism in HepG2 cells, results showed Silybin A decreased triglyceride levels and increased phospholipid content. | Theranostics. 2025 Jan 6;15(5):2006-2034. |
| HepG2 cells | 2, 10, 50 µM | 24 hours | To evaluate the effect of Silybin on P450s activity under TG-induced ER stress, results showed that Silybin reversed the inhibition of P450s activity by TG | Acta Pharmacol Sin. 2023 Jan;44(1):133-144. |
| LX-2 cells | 20 μg/mL | 24 hours | Evaluate anti-hepatic fibrosis efficacy by inhibiting collagen I secretion. Results showed that NS-SLB and NS-SLB-HC significantly inhibited collagen I secretion. | Int J Nanomedicine. 2023 Sep 12;18:5197-5211. |
| HK2 cells | 50 µM | 24 hours | To evaluate the effect of Silybin A on cisplatin-induced mitochondrial dysfunction and apoptosis in HK2 cells. Results showed that Silybin A improved mitochondrial function, reduced ROS production, and decreased apoptosis. | Front Pharmacol. 2017 Apr 5;8:178. |
| OVCAR3 cells | 50 µM and 100 µM | 24 hours and 48 hours | SIL inhibits cell proliferation and induces morphological changes by increasing ROS levels. | Cancer Sci. 2022 Sep;113(9):3032-3043. |
| RAW264.7 mouse macrophages | 50 and 100 µM | 3 hours | Inhibited LPS-induced NF-κB phosphorylation and nuclear translocation, reduced TNF-α and IL-1β mRNA/protein expression | Int J Mol Med. 2017 May;39(5):1111-1118. |
| RAW 264.7 cells | 1.0 μg/mL to 50 μg/mL | 48 hours | Evaluate cytotoxicity. Results showed that SLB displayed low toxicity against RAW 264.7 cells at concentrations up to 50 μg/mL. | Int J Nanomedicine. 2023 Sep 12;18:5197-5211. |
| LO2 cells | 1.0 μg/mL to 50 μg/mL | 48 hours | Evaluate cytotoxicity. Results showed that SLB displayed low toxicity against LO2 cells at concentrations up to 50 μg/mL. | Int J Nanomedicine. 2023 Sep 12;18:5197-5211. |
| HepG2 cells | 1.0 μg/mL to 50 μg/mL | 48 hours | Evaluate cytotoxicity. Results showed that SLB displayed low toxicity against HepG2 cells at concentrations up to 50 μg/mL. | Int J Nanomedicine. 2023 Sep 12;18:5197-5211. |
| HepG2 cells | 68 µM (IC50) | 72 hours | To study the effect of Silybin on HepG2 cell growth, results showed that Silybin inhibited cell growth by blocking the cell cycle in G1 phase and activating programmed cell death. | Int J Mol Sci. 2019 May 3;20(9):2190. |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| BALB/c nude mice | Ovarian cancer xenograft model | Oral gavage | 100 mg/kg | Once daily for 6 weeks | SIL controls cancer tissue growth by inhibiting IDH1 expression. | Cancer Sci. 2022 Sep;113(9):3032-3043. |
| SV129 mice | Cisplatin-induced acute kidney injury model | Intragastric administration | 200 mg/kg | Once daily for 7 days before and 3 days after cisplatin injection | To evaluate the protective effect of Silybin A on cisplatin-induced acute kidney injury. Results showed that Silybin A significantly reduced blood urea nitrogen levels, improved renal tubular injury, and enhanced mitochondrial function in a SIRT3-dependent manner. | Front Pharmacol. 2017 Apr 5;8:178. |
| C57BL/6 mice | Healthy mice | Intraperitoneal injection | 200 mg/kg | Three times (at 0, 12, and 24 h), sacrificed after 37 h | To investigate the effects of Silybin A on liver lipid metabolism in mice, results showed Silybin A increased hepatic phospholipid content and decreased triglyceride levels. | Theranostics. 2025 Jan 6;15(5):2006-2034. |
| C57BL/6J mice | Renal ischemia-reperfusion injury (IRI)-induced acute kidney injury (AKI) model | Intraperitoneal injection | 25 mg/kg, 50 mg/kg, 100 mg/kg | Once daily for 3 consecutive days | To evaluate the protective effect of Silybin A on IRI-AKI, results showed that Silybin A significantly improved renal dysfunction and pathological damage, and inhibited ferroptosis | Redox Biol. 2024 Nov;77:103360. |
| C57/BL6 mice | LPS-induced acute lung injury model | Intragastric | 50 and 100 mg/kg | Once daily for 3 consecutive days | Attenuated LPS-induced pulmonary inflammatory cell infiltration, edema, and pathological damage; reduced TNF-α/IL-1β levels in BALF and serum; suppressed NF-κB phosphorylation | Int J Mol Med. 2017 May;39(5):1111-1118. |
| C57BL/6 mice | High-fat-diet induced nonalcoholic fatty liver disease model | Intragastric administration | 50, 100 mg/kg/day | Once daily for 4 weeks | To evaluate the effect of Silybin on P450s activity in HFD-induced NAFLD mice, results showed that Silybin dose-dependently reversed the inhibition of P450s activity by HFD | Acta Pharmacol Sin. 2023 Jan;44(1):133-144. |
| Kunming mice | CCl4-induced liver fibrosis model and bile duct ligation (BDL)-induced liver fibrosis model | Tail vein injection | 8 mg/kg SLB | Twice a week for 10 to 12 weeks | Evaluate the therapeutic effects of NS-SLB and NS-SLB-HC against hepatic fibrosis. Results showed that both nanosuspensions significantly alleviated hepatic fibrosis, reduced ALT and AST levels, and downregulated TGF-β expression. | Int J Nanomedicine. 2023 Sep 12;18:5197-5211. |
Tags: Silybin A | Silibinin A | Autophagy | Reactive Oxygen Species | anticancer agent | NF-κB inhibition | STAT3 inhibition | apoptosis induction | antioxidant | 22888-70-6
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


